dutasteride 0.5mg, tamsulosin hydrochloride 0.4mg 복합경구제 (품명: 듀오다트캡슐)

· Campbell-Walsh-Wein Urology, 11e. 2015, 145. Evaluation and Nonsurgical Management of Benign Prostatic Hyperplasia

· Goldman-Cecil Medicine, 26e, 2021, 120. BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS

· Essentials of Men’s Health, 2020, Chapter 18: Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

· Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I - Initial Work-up and Medical Management. J OF UROLOGY 2021; 206: 806-817

· European Association of Urology (EAU) Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). 2020

· 전립선비대증 진료권고안, 대한비뇨기과학회, 2015

· Lower urinary tract symptoms in men: management, NICE guideline (CG97), Last updated 3 June 2015

· Zhou et al. Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia, BMC Urology. 2019; 19; 17

· CG Roehrborn, et al. The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study, EUROPEAN UROLOGY, 2010; 57; 123-131.

· F Montorsi, et al. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study, BJU Int, 2011; 107(9); 1426-1431.

· J McConnell, et al. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia. N Engl J Med, 2003; 349; 2387-98.